Breaking News
Author : admin
ADSTILADRIN® Marks a New Era in Bladder Cancer Treatment with Robust Clinical and Real-World Data.
admin
2025/04/22
5ADSTILADRIN® (nadofaragene firadenovec-vncg), a novel gene therapy, is revolutionizin...
New Hope for Von Willebrand Disease: Biotech Innovation Gains Momentum with Star Therapeutics Leading the Charge.
Von Willebrand disease, the most common inherited bleeding disorder, is finally seein...
Singapore's Biotech Boom: 7 Startups Shaping the Industry in 2025.
Singapore’s biotech sector is experiencing a surge in innovation and growth, propelle...
Confo Therapeutics Secures $60 Million to Advance Agonistic GPCR Antibody Pipeline.
Belgium-based Confo Therapeutics has raised €60 million in a Series B financing round...
Six Biotech Innovators Leading the Charge in Bispecific Antibody Therapeutics.
With bispecific antibodies gaining traction in the biotech world for their dual-targe...
Antibody-Drug Conjugates: Pioneering Precision in Cancer Treatment.
Antibody-drug conjugates (ADCs) are transforming oncology by delivering targeted chem...
Basel Emerges as Europe’s Premier Biotech Powerhouse.
Basel’s thriving life sciences sector is setting the pace for innovation in Europe. W...
Emerging Biotech Firms Drive HIV Treatment Innovations in 2025.
In 2025, six emerging biotech companies are pioneering novel approaches to HIV treatm...
Please Accept Cookies for Better Performance